Pfizer (PFE) FY2024 results: revenue $63.6 billion, up 6.8% on the year
Pfizer Inc. (PFE) reported revenue of $63.6 billion for fiscal 2024, the year ended 31 December 2024, up 6.8% on the year before. Net income was $8.0 billion, up 279.0%, and diluted earnings per share $1.41. The figures are the company's own, from the 10-K it filed with the SEC on 27 February 2025.
Revenue
$63.6 billion
+6.8% on the year
FY2017FY2024
Operating margin
n/a
FY2017FY2024
Net income
$8.0 billion
+279.0% on the year
FY2017FY2024
Diluted EPS
$1.41
+281.1% on the year
FY2017FY2024
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2024
FY2023
FY2022
On the year
Last 8 years
Operating cash flow
12,744
8,700
29,267
+46.5%
Capital expenditure
2,909
3,907
3,236
-25.5%
Free cash flow
9,835
4,793
26,031
+105.2%
Free cash flow margin
15.5%
8.0%
25.7%
Cash from investing
2,652
-32,278
-15,783
Cash from financing
-17,140
26,066
-14,834
Depreciation and amortisation
7,013
6,290
5,064
+11.5%
Share-based compensation
877
525
872
+67.0%
Buybacks
0.0
0.0
2,000
Dividends paid
9,512
9,247
8,983
+2.9%
Dividend per share
$1.69
$1.65
$1.61
+2.4%
Diluted shares, weighted
5,700m
5,709m
5,733m
-0.2%
Balance sheet
$ million
FY2024
FY2023
FY2022
On the year
Last 8 years
Shareholders' equity
88,203
89,014
95,661
-0.9%
Non-controlling interest
294
274
256
+7.3%
Debt
64,351
71,888
35,829
-10.5%
Operating lease liabilities
2,286
2,626
2,597
-12.9%
Other liabilities
58,262
62,699
62,862
-7.1%
Total liabilities and equity
213,396
226,501
197,205
-5.8%
Fixed assets
18,393
18,940
16,274
-2.9%
Goodwill
68,527
67,783
51,375
+1.1%
Intangible assets
55,411
64,900
43,370
-14.6%
Investments
13,109
19,768
33,812
-33.7%
Cash and equivalents
1,043
2,853
416
-63.4%
Receivables
11,463
11,566
10,952
-0.9%
Inventory
10,851
10,189
8,981
+6.5%
Other assets
34,599
30,502
32,025
+13.4%
Total assets
213,396
226,501
197,205
-5.8%
10-K for the year ended 31 December 2024, filed 27 February 2025: the filing.